These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 26662855

  • 21. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
    Ezzeldin N, El-Lebedy D, Darwish A, El Bastawisy A, Abd Elaziz SH, Hassan MM, Saad-Hussein A.
    BMC Cancer; 2018 May 03; 18(1):525. PubMed ID: 29724170
    [Abstract] [Full Text] [Related]

  • 22. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
    Bloom J, Hinrichs AL, Wang JC, von Weymarn LB, Kharasch ED, Bierut LJ, Goate A, Murphy SE.
    Pharmacogenet Genomics; 2011 Jul 03; 21(7):403-16. PubMed ID: 21597399
    [Abstract] [Full Text] [Related]

  • 23. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.
    Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF.
    Cancer Epidemiol Biomarkers Prev; 2013 Apr 03; 22(4):708-18. PubMed ID: 23371292
    [Abstract] [Full Text] [Related]

  • 24. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
    Hosono H, Kumondai M, Arai T, Sugimura H, Sasaki T, Hirasawa N, Hiratsuka M.
    Drug Metab Pharmacokinet; 2015 Aug 03; 30(4):263-8. PubMed ID: 26091970
    [Abstract] [Full Text] [Related]

  • 25. Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.
    Fogli S, Saba A, Del Re M, Pistelli F, Aquilini F, Zucchi R, Palla A, Breschi MC, Carrozzi L, Danesi R.
    J Pharm Biomed Anal; 2016 Nov 30; 131():208-213. PubMed ID: 27599351
    [Abstract] [Full Text] [Related]

  • 26. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
    Williams JM, Gandhi KK, Benowitz NL.
    Cancer Epidemiol Biomarkers Prev; 2010 Oct 30; 19(10):2582-9. PubMed ID: 20719908
    [Abstract] [Full Text] [Related]

  • 27. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T.
    Clin Pharmacol Ther; 2006 Sep 30; 80(3):282-97. PubMed ID: 16952495
    [Abstract] [Full Text] [Related]

  • 28. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, Murphy M, Walton R.
    Clin Pharmacol Ther; 2006 Oct 30; 80(4):319-30. PubMed ID: 17015050
    [Abstract] [Full Text] [Related]

  • 29. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL, Swan GE, Jacob P, Lessov-Schlaggar CN, Tyndale RF.
    Clin Pharmacol Ther; 2006 Nov 30; 80(5):457-67. PubMed ID: 17112802
    [Abstract] [Full Text] [Related]

  • 30. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
    Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX.
    Int J Cancer; 2001 Mar 20; 95(2):96-101. PubMed ID: 11241319
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
    Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF.
    Nicotine Tob Res; 2003 Dec 20; 5(6):891-9. PubMed ID: 14668073
    [Abstract] [Full Text] [Related]

  • 34. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.
    Mwenifumbo JC, Al Koudsi N, Ho MK, Zhou Q, Hoffmann EB, Sellers EM, Tyndale RF.
    Hum Mutat; 2008 May 20; 29(5):679-88. PubMed ID: 18360915
    [Abstract] [Full Text] [Related]

  • 35. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.
    Binnington MJ, Zhu AZ, Renner CC, Lanier AP, Hatsukami DK, Benowitz NL, Tyndale RF.
    Pharmacogenet Genomics; 2012 Jun 20; 22(6):429-40. PubMed ID: 22569203
    [Abstract] [Full Text] [Related]

  • 36. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.
    Jacob P, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb 01; 879(3-4):267-76. PubMed ID: 21208832
    [Abstract] [Full Text] [Related]

  • 37. CYP2A6 metabolism in the development of smoking behaviors in young adults.
    Olfson E, Bloom J, Bertelsen S, Budde JP, Breslau N, Brooks A, Culverhouse R, Chan G, Chen LS, Chorlian D, Dick DM, Edenberg HJ, Hartz S, Hatsukami D, Hesselbrock VM, Johnson EO, Kramer JR, Kuperman S, Meyers JL, Nurnberger J, Porjesz B, Saccone NL, Schuckit MA, Stitzel J, Tischfield JA, Rice JP, Goate A, Bierut LJ.
    Addict Biol; 2018 Jan 01; 23(1):437-447. PubMed ID: 28032407
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
    Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Kamataki T.
    Carcinogenesis; 2004 Dec 01; 25(12):2451-8. PubMed ID: 15308589
    [Abstract] [Full Text] [Related]

  • 39. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
    Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE, Transdisciplinary Research in Cancer of the Lung Research Team.
    PLoS One; 2015 Dec 01; 10(7):e0126113. PubMed ID: 26132489
    [Abstract] [Full Text] [Related]

  • 40. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
    Murphy SE, Sipe CJ, Choi K, Raddatz LM, Koopmeiners JS, Donny EC, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2017 Jul 01; 26(7):1093-1099. PubMed ID: 28264876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.